<DOC>
	<DOC>NCT00233636</DOC>
	<brief_summary>The aim of the study is to determine if Iressa added to radiotherapy is effective and safe in shrinking tumour dimensions.</brief_summary>
	<brief_title>Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Squamous Cell</mesh_term>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Histologically Confirmed locally advanced Squamous Cell Carcinoma of Head and neck At least one measurable tumour lesion No previous treatment such as chemotherapy, radiotherapy and/or surgery for Carcinoma Head and Neck No other coexisting malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ Any evidence of severe or uncontrolled systemic disease (e.g. unstable or uncompensated respiratory, cardiac, hepatic or renal disease)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Squamous Cell Carcinoma of Head and Neck</keyword>
	<keyword>Inoperable locally advanced Squamous Cell Carcinoma of Head and Neck</keyword>
</DOC>